Overview

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

Summary

To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Bp Consulting, Inc

Treatments:

Bromfenac
Diclofenac
Ketorolac
Ketorolac Tromethamine